ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Elevance Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$430.23+1.97 (+0.46%)
Close on Oct 19, 2026
- Market cap
- $93.75B
- P/E (TTM)
- 19.1
- Dividend yield
- –
Elevance Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Hospital & Medical Service Plans companies for comparison
Valuation
| Measure | Elevance Health | Industry median |
|---|---|---|
| Market Cap | $93.30B | $3.25B |
| Enterprise Value | $88.54B | $2.52B |
| PE Ratio | 19.12 | 10.32 |
| PS Ratio | 0.46 | 1.08 |
| PB Ratio | 2.08 | 1.48 |
| P/TBV Ratio | 16.78 | 1.56 |
| P/FCF Ratio | 14.84 | 7.95 |
| P/OCF Ratio | 12.50 | 7.31 |
Enterprise value
| Measure | Elevance Health | Industry median |
|---|---|---|
| EV / Sales | 0.44 | 0.93 |
| EV / EBITDA | 12.71 | 6.24 |
| EV / EBIT | 16.24 | 7.37 |
| EV / FCF | 14.08 | 7.33 |
Income (trailing twelve months)
| Measure | Elevance Health | Industry median |
|---|---|---|
| Revenue | $201.11B | $4.57B |
| Gross Profit | $179.26B | $5.63B |
| Operating Income | $5.45B | $617.20M |
| Pretax Income | $5.86B | $589.53M |
| Net Income | $4.96B | $470.80M |
| EBITDA | $6.97B | $657.96M |
| EPS (Diluted) | $22.50 | $4.71 |
Margins
| Measure | Elevance Health | Industry median |
|---|---|---|
| Gross Margin | 89.1% | 31.0% |
| Operating Margin | 2.71% | 4.46% |
| Pretax Margin | 2.91% | 13.7% |
| Profit Margin | 2.47% | 10.7% |
| EBITDA Margin | 3.46% | 13.5% |
| FCF Margin | 3.13% | 17.5% |
Returns
| Measure | Elevance Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.2% | 13.9% |
| Return on Assets (ROA) | 4.00% | 3.31% |
| Return on Invested Capital (ROIC) | 11.5% | 19.7% |
| Return on Capital Employed (ROCE) | 6.64% | 6.00% |
Growth
| Measure | Elevance Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.29% | 8.06% |
| Net Income Growth (YoY) | -7.41% | 25.1% |
| EPS Growth (YoY) | -4.26% | 27.7% |
| FCF Growth (YoY) | 17.8% | 7.71% |
| Revenue Growth (3Y CAGR) | 8.34% | 9.53% |
| Revenue Growth (5Y CAGR) | 10.3% | 8.29% |
| EPS Growth (3Y CAGR) | 1.26% | 15.9% |
| EPS Growth (5Y CAGR) | 6.99% | 15.2% |
Balance sheet
| Measure | Elevance Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $35.95B | $482.49M |
| Total Debt | $31.04B | $859.00M |
| Net Cash (Debt) | $4.91B | $300.85M |
| Net Cash Per Share | $22.63 | $5.27 |
| Equity (Book Value) | $44.88B | $3.63B |
| Book Value Per Share | $206.96 | $41.34 |
| Tangible Book Value | $5.56B | $2.59B |
| Working Capital | $22.93B | $313.96M |
Financial position
| Measure | Elevance Health | Industry median |
|---|---|---|
| Current Ratio | 1.52 | 1.45 |
| Quick Ratio | 0.81 | 0.98 |
| Debt / Equity | 0.69 | 0.27 |
| Debt / EBITDA | 4.46 | 2.36 |
| Debt / FCF | 4.94 | 2.10 |
| Net Debt / EBITDA | -0.70 | -0.40 |
| Interest Coverage | 3.79 | 4.13 |
Cash flow (trailing twelve months)
| Measure | Elevance Health | Industry median |
|---|---|---|
| Operating Cash Flow | $7.46B | $631.50M |
| Capital Expenditures | -$1.18B | -$11.90M |
| Free Cash Flow | $6.29B | $661.55M |
| FCF Per Share | $29.00 | $8.91 |
Efficiency
| Measure | Elevance Health | Industry median |
|---|---|---|
| Asset Turnover | 1.62 | 0.27 |
| Revenue Per Employee | $2.07M | $1.73M |
| Profits Per Employee | $51.11K | $208.67K |
| Employee Count | 97,100 | 1,341 |
Dividends and yields
| Measure | Elevance Health | Industry median |
|---|---|---|
| Earnings Yield | 5.32% | 9.51% |
| FCF Yield | 6.74% | 12.5% |
| Buyback Yield | 2.90% | 2.89% |
| Shareholder Yield | 2.90% | 4.63% |
| Payout Ratio | 30.3% | 20.2% |
| FCF Payout Ratio | 23.9% | 16.0% |
Shares
| Measure | Elevance Health | Industry median |
|---|---|---|
| Shares Outstanding | 216,869,000 | 65,596,200 |
| Shares Change (YoY) | -3.63% | -1.19% |
| Shares Change (QoQ) | -0.24% | -0.31% |
| Float | 216,465,000 | 56,719,400 |
| Shares Held by Insiders | 0.19% | 3.34% |
| Shares Held by Institutions | 94.0% | 85.3% |
Taxes
| Measure | Elevance Health | Industry median |
|---|---|---|
| Income Tax | $915.00M | $105.00M |
| Effective Tax Rate | 15.6% | 19.8% |
Scores
| Measure | Elevance Health | Industry median |
|---|---|---|
| Graham Number | $323.69 | $76.86 |
| Graham Upside | -24.8% | 20.9% |
| Altman Z-Score | 3.04 | 0.87 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Elevance Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.